Flexpa, a company focused on enhancing patient access to health data, recently announced it has raised an $8.5 million seed funding round led by Andreessen Horowitz (a16z). This significant investment aims to further the development and scaling of Flexpa's API, which provides patients with free and secure access to their clinical and claims data. The funding round also saw participation from notable investors including BoxGroup and Village Global, alongside various individual angels.
The company's co-founder and CEO, Andrew Arruda, highlighted Flexpa's mission to empower individuals with their health information. "we’re building @flexpa so this is possible for health data. with flexpa your current, up to date clinical and claims data (insurance) is all available by API," Arruda stated in a social media post. He further encouraged patients to try the service themselves and download their AI-powered application.
Flexpa's platform is designed to streamline the often-complex process of accessing personal health records, leveraging regulations like the 21st Century Cures Act. This legislation mandates greater interoperability in healthcare, requiring health plans and providers to offer standardized APIs for patient data access. By building on the FHIR standard, Flexpa ensures secure and efficient data transfer, aligning with industry efforts to break down data silos.
Andrew Arruda, previously the co-founder and CEO of ROSS Intelligence, an AI-powered legal research platform, brings extensive experience in artificial intelligence and entrepreneurship to the healthcare sector. His vision for Flexpa is rooted in using technology to solve critical data accessibility challenges, a mission supported by the current market trend towards patient-centric healthcare. The company's offering, which includes an AI-powered app, aims to make health data more actionable and understandable for patients.
The $8.5 million in seed funding will be strategically deployed to expand Flexpa's engineering team, accelerate product development, and broaden its platform's integration capabilities with more health plans and providers. This investment underscores the growing recognition of the need for robust, patient-controlled health data solutions in a rapidly evolving digital healthcare landscape.
